Heterologous ("Nonspecific") and Sex-Differential Effects of Vaccines: Epidemiology, Clinical Trials, and Emerging Immunologic Mechanisms
KL Flanagan, R van Crevel, N Curtis, F Shann, O Levy
Clinical Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2013
Awarded by Danish National Research Foundation
Awarded by National Institutes of Health
Awarded by Bill & Melinda Gates Foundation
Awarded by Medical Research Council
The Second Optimmunize Meeting was funded by the Novo Nordisk Foundation, Denmark, and by the Danish National Research Foundation (DNRF108). R. vC. is funded by a VIDI grant from the Netherlands Organization for Scientific Research Foundation; N. C. has received grants from the Australian National Health and Medical Research Council (NHMRC); O. L. is funded by the National Institutes of Health (grant number R01-AI100135-01) and the Bill & Melinda Gates Foundation (global health grant numbers OPPGH5284 and OPP1035192); K. L. F. has received funds from NHMRC and Clifford Craig Research Trust. O. L.'s laboratory has received sponsorship and reagent support from 3M Drug Delivery Systems and VentiRx Pharmaceuticals.